New Zealand markets close in 1 hour 12 minutes

OrbusNeich Medical Group Holdings Limited (6929.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
4.120-0.110 (-2.60%)
As of 11:31AM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 3.50B
Enterprise value 1.56B
Trailing P/E 10.01
Forward P/E 13.51
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.93
Price/book (mrq)1.22
Enterprise value/revenue 1.30
Enterprise value/EBITDA 3.71

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-66.48%
S&P500 52-week change 326.36%
52-week high 313.100
52-week low 33.010
50-day moving average 33.608
200-day moving average 36.359

Share statistics

Avg vol (3-month) 3248.59k
Avg vol (10-day) 3258.65k
Shares outstanding 5827.97M
Implied shares outstanding 6827.97M
Float 8235.91M
% held by insiders 163.03%
% held by institutions 112.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.1
Forward annual dividend yield 42.36%
Trailing annual dividend rate 30.01
Trailing annual dividend yield 30.31%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 411 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 29.29%
Operating margin (ttm)21.21%

Management effectiveness

Return on assets (ttm)6.46%
Return on equity (ttm)13.03%

Income statement

Revenue (ttm)153.86M
Revenue per share (ttm)0.19
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)N/A
EBITDA 41.3M
Net income avi to common (ttm)45.07M
Diluted EPS (ttm)0.420
Quarterly earnings growth (yoy)90.30%

Balance sheet

Total cash (mrq)256.21M
Total cash per share (mrq)0.31
Total debt (mrq)7.46M
Total debt/equity (mrq)2.02%
Current ratio (mrq)9.77
Book value per share (mrq)0.44

Cash flow statement

Operating cash flow (ttm)23.03M
Levered free cash flow (ttm)5.32M